111 related articles for article (PubMed ID: 16950499)
21. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
22. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral vector integration sites in human NOD/SCID repopulating cells.
Laufs S; Guenechea G; Gonzalez-Murillo A; Zsuzsanna Nagy K; Luz Lozano M; del Val C; Jonnakuty S; Hotz-Wagenblatt A; Jens Zeller W; Bueren JA; Fruehauf S
J Gene Med; 2006 Oct; 8(10):1197-207. PubMed ID: 16960916
[TBL] [Abstract][Full Text] [Related]
24. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
[TBL] [Abstract][Full Text] [Related]
25. New methods to titrate EIAV-based lentiviral vectors.
Martin-Rendon E; White LJ; Olsen A; Mitrophanous KA; Mazarakis ND
Mol Ther; 2002 May; 5(5 Pt 1):566-70. PubMed ID: 11991747
[TBL] [Abstract][Full Text] [Related]
26. Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada.
Nagarajan MM; Simard C
Virus Res; 2007 Nov; 129(2):228-35. PubMed ID: 17767972
[TBL] [Abstract][Full Text] [Related]
27. DNA transposons for modification of human primary T lymphocytes.
Huang X; Wilber A; McIvor RS; Zhou X
Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
[TBL] [Abstract][Full Text] [Related]
28. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
29. Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.
Farley DC; Bannister R; Leroux-Carlucci MA; Evans NE; Miskin JE; Mitrophanous KA
Hum Gene Ther Methods; 2012 Oct; 23(5):309-23. PubMed ID: 23121195
[TBL] [Abstract][Full Text] [Related]
30. Cold spots in hot spots: transcription start sites of active genes are spared from HIV vector integration.
Giordano FA; Appelt JU; Zucknick M; Abba M; Zeller WJ; Fruehauf S; Allgayer H; Laufs S
AIDS; 2009 Nov; 23(18):2535-7. PubMed ID: 19841571
[TBL] [Abstract][Full Text] [Related]
31. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
[TBL] [Abstract][Full Text] [Related]
32. Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors.
O'Rourke JP; Hiraragi H; Urban K; Patel M; Olsen JC; Bunnell BA
Mol Ther; 2003 May; 7(5 Pt 1):632-9. PubMed ID: 12718906
[TBL] [Abstract][Full Text] [Related]
33. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
[TBL] [Abstract][Full Text] [Related]
34. A high throughput method for genome-wide analysis of retroviral integration.
Mantovani J; Holic N; Martinez K; Danos O; Perea J
Nucleic Acids Res; 2006; 34(19):e134. PubMed ID: 17028098
[TBL] [Abstract][Full Text] [Related]
35. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
36. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
[TBL] [Abstract][Full Text] [Related]
37. Construction of a novel human artificial chromosome vector for gene delivery.
Katoh M; Ayabe F; Norikane S; Okada T; Masumoto H; Horike S; Shirayoshi Y; Oshimura M
Biochem Biophys Res Commun; 2004 Aug; 321(2):280-90. PubMed ID: 15358173
[TBL] [Abstract][Full Text] [Related]
38. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
Berger G; Goujon C; Darlix JL; Cimarelli A
Gene Ther; 2009 Jan; 16(1):159-63. PubMed ID: 18668143
[TBL] [Abstract][Full Text] [Related]
39. Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome.
Mantovani J; Charrier S; Eckenberg R; Saurin W; Danos O; Perea J; Galy A
J Gene Med; 2009 Aug; 11(8):645-54. PubMed ID: 19455589
[TBL] [Abstract][Full Text] [Related]
40. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
Mitchell RS; Beitzel BF; Schroder AR; Shinn P; Chen H; Berry CC; Ecker JR; Bushman FD
PLoS Biol; 2004 Aug; 2(8):E234. PubMed ID: 15314653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
